Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
99 100 Next >
First-Ever Autoimmune Diseases Registry Launches New Website Powered by the NIH’s All of Us Research Program
Via AB Newswire
Exposures Product Safety
China’s efforts in desertification control reflect harmonious coexistence between humanity and nature
Via Prodigy
Topics Climate Change Energy Product Recall
Exposures Climate Electricity Generation Legal
Acquisition of Kadima Neuropsychiatry Institute for CNS & Psychedelic Research Planned; New Drug Application for Suicidal Depression Treatment: $NRXP
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers JPM
New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP
Via PRLog
Exposures Product Safety
Tickers JPM
Health Care Equipment Supplier CytoSorbents Shares Dip Despite Projected Revenue Growth
Via Benzinga
Topics Supply Chain
Exposures Product Safety Supply Chain
Tickers CTSO
Carmell, Mustang Bio, Revelation Biosciences Dominate Retail Biotech Talk As 2025 Kicks Off
Via Stocktwits
Exposures Product Safety
Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'
Via Benzinga
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers LLY
Tesla Recalls In 2024 Crossed 5 Million, But Most Were Fixed Via Software Updates: Majority Of Physical Recalls Were For This Vehicle
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers TSLA
Why Is Brain Cancer-Focused Kazia Therapeutics Stock Trading Lower On Tuesday?
Via Benzinga
Exposures Product Safety
Tickers KZIA
Why Is FTAI Aviation (FTAI) Stock Rocketing Higher Today
Via StockStory
Topics Product Recall
Exposures Legal Product Safety
Tickers BA FTAI
Why Is Cancer-Focused Verastem Oncology Stock Trading Higher On Tuesday?
Via Benzinga
Exposures Product Safety
Tickers VSTM
FDA And Nuwellis Address Potentially High-Risk Issue With Blood Circuit Device
Via Benzinga
Exposures Product Safety
Tickers NUWE
Axsome Reveals Data From Alzheimer's Studies, Analyst Sees Hope Despite Mixed Trial Results
Via Benzinga
Exposures Product Safety
Tickers AXSM ITCI JNJ OTSKF
Tesla Recalls Nearly 78,000 Model 3, Model Y Vehicles In China
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers TSLA
New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects Over 13 Million Americans Each Year: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
Via Get News
Exposures Product Safety
Tickers NRXP
DENTSPLY SIRONA Inc. (XRAY) Investors: January 27, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
Axsome Therapeutics Stock Tumbles As Alzheimer's Studies Reveal Mixed Results: Retail Sentiment Remains Bullish
Via Stocktwits
Exposures Product Safety
Applied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Class Action Announcement (APLT): A Securities Fraud Class Action Lawsuit Was Filed Against Applied Therapeutics, Inc.
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
XRAY Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DENTSPLY SIRONA Inc. (XRAY)
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
Kaplan Fox Has Filed a Class Action to Recover Losses for Investors Who Purchased Common Stock of Applied Therapeutics, Inc. (NASDAQ: APLT)
Via NewMediaWire
Exposures Product Safety
Tickers APLT
Bristol Myers Squibb Stock In Focus After FDA Approves Cancer Drug: Retail Sentiment Brightens
Via Stocktwits
Exposures Product Safety
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Receives FDA Roadmap on Potential Accelerated Pathway for CNM-Au8(R)
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
Kessler Topaz Meltzer & Check, LLP Reminds APLT Shareholders of Deadline in Securities Fraud Class Action Lawsuit Filed Against Applied Therapeutics, Inc. (APLT)
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
XRAY ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against DENTSPLY SIRONA Inc. (XRAY)
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
Clene Inc. (NASDAQ: CLNN) Improves Cash Position and Runway with New Debt Facility for CNM-Au8(R) Data Collection to Support Accelerated Approval Application
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
APLT DEADLINE FOR LEADERSHIP is February 18, 2025 in a Securities Fraud Lawsuit - Contact Kaplan Fox
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)
Via Newsfile
Exposures Product Safety
Tickers ELTP
Global Times: Chinese-built hydropower station lights up homes of remote Lao village, dreams of prosperity
Via Get News
Topics Product Recall
Exposures Legal Product Safety
APPLIED THERAPEUTICS DEADLINE FOR LEADERSHIP is February 18, 2025 in a Securities Fraud Lawsuit - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.